Photodynamic therapy in patients with colorectal cancer
β Scribed by Lemuel Herrera-Ornelas; Nicholas J. Petrelli; Arnold Mittelman; Thomas J. Dougherty; Donn G. Boyle
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 756 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Six patients with an early stage of gastrointestinal (GI) cancer (TINoMo, stage I) were successfully treated by photodynamic therapy (PDT) as follows: esophagus-1, stomach-2, rectum-3. The patients were photosensitized 72 hrs rior to treatment with pure venous infusion. Argon-pumped dye laser light
Background and Objectives: Chest wall recurrence occurs in 5-20% of breast cancer patients. Until recently, the only treatments available were surgical resection or radiotherapy. Photodynamic therapy (PDT) is a new modality that uses a photosensitizer and light to destroy tumor cells selectively. We
A 63-year-old male, status post-right pneumonectomy, presented with hemoptysis. Although chest X-ray and CAT scan film findings were negative, bronchoscopy with biopsy from the left mainstem bronchus demonstrated squamous cell carcinoma. Because of the inoperable location of the lesion, the patient
Conflicting data exist on the prognosis of hereditary colorectal cancer. HNPCC patients, in particular, are often reported to have a better survival. We examined 2,340 colorectal-cancer patients treated in our Institution: 144 HNPCC patients (Amsterdam Criteria), 161 FAP patients and 2,035 patients